Stay updated on Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page
- ChecktodayChange DetectedThe record history now shows Revision: v3.7.0 as the latest update, and the previous Revision: v3.6.6 is removed from the list.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision entry v3.6.6 was added to the Study Record History, replacing the previous v3.6.5.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page history now shows a new revision tag (v3.6.5) replacing the previous v3.6.4, indicating a new version of the record history. This is a minor system update and does not change the study data or its visibility.SummaryDifference0.0%

- Check58 days agoChange DetectedA new version of the study record (v3.6.4) was published on 2026-07-23, introducing the Contacts/Locations and Study Status sections; the prior revision (v3.6.3) was removed on 2026-03-30.SummaryDifference0.2%

- Check79 days agoChange DetectedThe history list now includes Revision: v3.6.3, replacing the previous v3.6.2. This indicates a new revision entry for the page in the record history.SummaryDifference0.0%

- Check86 days agoChange DetectedA new revision entry v3.6.2 was added to the history, and the older v3.6.0 entry was removed. This reflects an update to the page's revision history.SummaryDifference0.0%

Stay in the know with updates to Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.